KRAS and urothelial carcinoma: Uromonitor<sup>®</sup> is a quantitative PCR-based assay targeting hotspot variants in the <i>TERT</i> promoter, <i>FGFR3</i>, and <i>KRAS</i>, which are frequently altered in urothelial carcinoma.